EYPT · XBRL financial data

EyePoint financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (EYPT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	34	37	41	46	43	31
Research and development	17	29	50	65	133	221
General and administrative	21	26	35	40	52	52
Total operating expenses	72	92	141	121	189	275
Operating income (loss)	(37)	(55)	(100)	(75)	(146)	(243)
Interest expense	7	5	3	1	0	0
Other income (expense)	0	0	2	7	15	12
Income tax expense (benefit)	0	0	0	0	0	0
Net income (loss)	(45)	(58)	(102)	(71)	(131)	(232)
Earnings per share, basic USD per share	—	(2.03)	(2.74)	(1.82)	(2.32)	(3.17)
Earnings per share, diluted USD per share	—	(2.03)	(2.74)	(1.82)	(2.32)	(3.17)
Weighted average shares, basic millions of shares	—	29	37	39	0	0
Weighted average shares, diluted millions of shares	—	29	37	39	0	0

Fiscal years (EYPT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	45	179	96	281	100	102
Marketable securities	0	33	49	50	271	204
Inventory	5	4	3	4	2	2
Prepaid and other current assets	3	4	10	9	9	20
Total current assets	63	238	173	345	383	329
Property and equipment, net	1	0	1	5	8	9
Right-of-use asset	3	2	6	5	21	20
Total assets	92	263	180	355	418	364
Accounts payable	5	7	6	7	12	10
Accrued liabilities	8	14	16	18	18	24
Total current liabilities	15	24	35	63	49	37
Long-term debt	38	37	29	—	—	—
Lease liability, non-current	2	2	6	5	22	21
Total liabilities	73	79	84	89	82	58
Accumulated deficit	(511)	(569)	(671)	(742)	(873)	(1,105)
Total stockholders' equity	19	184	96	266	337	306
Total liabilities and equity	92	263	180	355	418	364
Common shares outstanding (cover page) millions of shares	29	34	34	50	69	83

Fiscal years (EYPT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(45)	(58)	(102)	(71)	(131)	(232)
Stock-based compensation	6	7	14	12	37	28
Depreciation and amortization	—	—	—	—	2	2
Net cash from operating activities	(14)	(50)	(65)	2	(126)	(240)
Purchases of property and equipment	0	0	2	3	4	3
Net cash from investing activities	(0)	(33)	(17)	(3)	(219)	69
Proceeds from issuing common stock	50	—	0	226	163	173
Proceeds from long-term debt	—	0	30	0	—	—
Repayments of long-term debt	14	0	38	30	0	—
Net cash from financing activities	37	217	(1)	187	164	174
Net change in cash	23	134	(83)	186	(182)	2

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
EyePoint	110	0.5	(62)*	86.2M	2.9 quarters	Q2 FY26 10-QJun 30, 2026
Transcat	5.8	97	10*	9.4M	—	Q2 FY27 10-QSep 26, 2026
Aehr Test Systems	116	19*	1.8*	32.6M	—	Q4 FY26 10-KMay 29, 2026
Allient	40	164	2*	17.0M	—	Q3 FY26 10-QSep 30, 2026
Cohu	272	173	5.6*	47.3M	—	Q3 FY26 10-QSep 26, 2026
Cytek Biosciences	67	53	(4.5)*	130.8M	17.1 quarters	Q3 FY26 10-QSep 30, 2026
Senseonics Holdings	45	14	(30)*	52.9M	4.7 quarters	Q2 FY26 10-QJun 30, 2026
Pacific Biosciences of California	61	39	(36)*	310.8M	6.7 quarters	Q2 FY26 10-QJun 30, 2026
Mesa Laboratories	31	60	15	5.6M	—	Q1 FY27 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.